Analysis of antibodies to neuronal surface antigens in adult opsoclonus-myoclonus

Journal of Neuroimmunology

Volumn 196, Issue 1-2, 2008, Pages 188-191

  Sabater, L ^a   Xifro X ^b   Saiz, A ^a   Alberch, J ^b   Graus, F ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

Author keywords

Autoantibodies; Cerebellar granular neurons; Opsoclonus myoclonus syndrome

Indexed keywords

ANTIBODY; MEMBRANE ANTIGEN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; IDIOPATHIC DISEASE; IMMUNITY; IMMUNOCYTOCHEMISTRY; NERVE CELL; NONHUMAN; OPSOCLONUS MYOCLONUS SYNDROME; PARANEOPLASTIC SYNDROME; PRIORITY JOURNAL; RAT; STATISTICAL SIGNIFICANCE;

ADULT; AGED; ANIMALS; ANTIBODIES; ANTIGENS, SURFACE; CELLS, CULTURED; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MIDDLE AGED; NEURONS; OPSOCLONUS-MYOCLONUS SYNDROME; RATS; RATS, WISTAR;

EID: 44549087725     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2008.03.013     Document Type: Article

References (18)

1. Anderson N.E., Budde-Steffen C., Rosenblum M.K., Graus F., Ford D., Synek B.J., and Posner J.B. Opsoclonus, myoclonus, ataxia, and encephalopathy in adults with cancer: a distinct paraneoplastic syndrome. Medicine (Baltimore) 67 (1988) 100-109
2. Antunes N.L., Khakoo Y., Matthay K.K., Seeger R.C., Stram D.O., Gerstner E., Abrey L.E., and Dalmau J. Antineuronal antibodies in patients with neuroblastoma and paraneoplastic opsoclonus-myoclonus. J. Pediatr. Hematol. Oncol. 22 (2000) 315-320
3. Balazs R., Jorgensen O.S., and Hack N. N-methyl-d-aspartate promotes the survival of cerebellar granule cells in culture. Neuroscience 27 (1988) 437-451
4. Bataller L., Graus F., Saiz A., and Vilchez J.J. Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus. Brain 124 (2001) 437-443
5. Bataller L., Rosenfeld M.R., Graus F., Vilchez J.J., Cheung N.K., and Dalmau J. Autoantigen diversity in the opsoclonus-myoclonus syndrome. Ann. Neurol. 53 (2003) 347-353
6. Blaes F., Fuhlhuber V., Korfei M., Tschernatsch M., Behnisch W., Rostasy K., Hero B., Kaps M., and Preissner K.T. Surface-binding autoantibodies to cerebellar neurons in opsoclonus syndrome. Ann. Neurol. 58 (2005) 313-317
7. Candler P.M., Dale R.C., Griffin S., Church A.J., Wait R., Chapman M.D., Keir G., Giovannoni G., and Rees J.H. Post-streptococcal opsoclonus-myoclonus syndrome associated with anti-neuroleukin antibodies. J. Neurol. Neurosurg. Psychiatry 77 (2006) 507-512
8. Connolly A.M., Pestronk A., Mehta S., Pranzatelli III M.R., and Noetzel M.J. Serum autoantibodies in childhood opsoclonus-myoclonus syndrome: an analysis of antigenic targets in neural tissues. J. Pediatr. 130 (1997) 878-884
9. Dalmau J., Tuzun E., Wu H.Y., Masjuan J., Rossi J.E., Voloschin A., Baehring J.M., Shimazaki H., Koide R., King D., Mason W., Sansing L.H., Dichter M.A., Rosenfeld M.R., and Lynch D.R. Paraneoplastic anti-N-methyl-d-aspartate receptor encephalitis associated with ovarian teratoma. Ann. Neurol. 61 (2007) 25-36
10. Kinsbourne M. Myoclonic encephalopathy of infants. J. Neurol. Neurosurg. Psychiatry 25 (1963) 221-276
11. Korfei M., Fuhlhuber V., Schmidt-Woll T., Kaps M., Preissner K.T., and Blaes F. Functional characterisation of autoantibodies from patients with pediatric opsoclonus-myoclonus-syndrome. J. Neuroimmunol. 170 (2005) 150-157
12. Luque F.A., Furneaux H.M., Ferziger R., Rosenblum M.K., Wray S.H., Schold Jr. S.C., Glantz M.J., Jaeckle K.A., Biran H., Lesser M., et al. Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer. Ann. Neurol. 29 (1991) 241-251
13. Pranzatelli M.R. The immunopharmacology of the opsoclonus-myoclonus syndrome. Clin. Neuropharmacol. 19 (1996) 1-47
14. Pranzatelli M.R., Travelstead A.L., Tate E.D., Allison T.J., Moticka E.J., Franz D.N., Nigro M.A., Parke J.T., Stumpf D.A., and Verhulst S.J. B- and T-cell markers in opsoclonus-myoclonus syndrome: immunophenotyping of CSF lymphocytes. Neurology 62 (2004) 1526-1532
15. Saiz A., Arpa J., Sagasta A., Casamitjana R., Zarranz J.J., Tolosa E., and Graus F. Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late-onset insulin-dependent diabetes mellitus, and polyendocrine autoimmunity. Neurology 49 (1997) 1026-1030
16. Stefansson K., Marton L.S., Dieperink M.E., Molnar G.K., Schlaepfer W.W., and Helgason C.M. Circulating autoantibodies to the 200,000-Dalton protein of neurofilaments in the serum of healthy individuals. Science 228 (1985) 1117-1119
17. Xifro X., Malagelada C., Minano A., and Rodriguez-Alvarez J. Brief exposure to NMDA produces long-term protection of cerebellar granule cells from apoptosis. Eur. J. Neurosci. 21 (2005) 827-840
18. Wong A. An update on opsoclonus. Curr. Opin. Neurol. 20 (2007) 25-31